460 related articles for article (PubMed ID: 21628511)
1. Sterile protective immunity to malaria is associated with a panel of novel P. falciparum antigens.
Trieu A; Kayala MA; Burk C; Molina DM; Freilich DA; Richie TL; Baldi P; Felgner PL; Doolan DL
Mol Cell Proteomics; 2011 Sep; 10(9):M111.007948. PubMed ID: 21628511
[TBL] [Abstract][Full Text] [Related]
2. Current Challenges in the Identification of Pre-Erythrocytic Malaria Vaccine Candidate Antigens.
Bettencourt P
Front Immunol; 2020; 11():190. PubMed ID: 32153565
[No Abstract] [Full Text] [Related]
3. Antibody Biomarkers Associated with Sterile Protection Induced by Controlled Human Malaria Infection under Chloroquine Prophylaxis.
Obiero JM; Campo JJ; Scholzen A; Randall A; Bijker EM; Roestenberg M; Hermsen CC; Teng A; Jain A; Davies DH; Sauerwein RW; Felgner PL
mSphere; 2019 Feb; 4(1):. PubMed ID: 30787114
[TBL] [Abstract][Full Text] [Related]
4. Novel sporozoite-based ELISpot assay to assess frequency of parasite-specific B cells after vaccination with irradiated sporozoites.
Atre T; Robinson TM; Savransky T; Dutta S; Epstein JE; Bergmann-Leitner ES
Malar J; 2019 May; 18(1):186. PubMed ID: 31142328
[TBL] [Abstract][Full Text] [Related]
5. Breadth of humoral response and antigenic targets of sporozoite-inhibitory antibodies associated with sterile protection induced by controlled human malaria infection.
Peng K; Goh YS; Siau A; Franetich JF; Chia WN; Ong AS; Malleret B; Wu YY; Snounou G; Hermsen CC; Adams JH; Mazier D; Preiser PR; Sauerwein RW; Grüner AC; Rénia L
Cell Microbiol; 2016 Dec; 18(12):1739-1750. PubMed ID: 27130708
[TBL] [Abstract][Full Text] [Related]
6. Early whole blood transcriptional responses to radiation-attenuated Plasmodium falciparum sporozoite vaccination in malaria naïve and malaria pre-exposed adult volunteers.
Duffy FJ; Du Y; Carnes J; Epstein JE; Hoffman SL; Abdulla S; Jongo S; Mpina M; Daubenberger C; Aitchison JD; Stuart K
Malar J; 2021 Jul; 20(1):308. PubMed ID: 34243763
[TBL] [Abstract][Full Text] [Related]
7. Liver-Directed AAV8 Booster Vaccine Expressing
Shahnaij M; Iyori M; Mizukami H; Kajino M; Yamagoshi I; Syafira I; Yusuf Y; Fujiwara K; Yamamoto DS; Kato H; Ohno N; Yoshida S
Front Immunol; 2021; 12():612910. PubMed ID: 34248928
[TBL] [Abstract][Full Text] [Related]
8. Discovery of Novel Plasmodium falciparum Pre-Erythrocytic Antigens for Vaccine Development.
Aguiar JC; Bolton J; Wanga J; Sacci JB; Iriko H; Mazeika JK; Han ET; Limbach K; Patterson NB; Sedegah M; Cruz AM; Tsuboi T; Hoffman SL; Carucci D; Hollingdale MR; Villasante ED; Richie TL
PLoS One; 2015; 10(8):e0136109. PubMed ID: 26292257
[TBL] [Abstract][Full Text] [Related]
9. Profiling humoral immune responses to P. falciparum infection with protein microarrays.
Doolan DL; Mu Y; Unal B; Sundaresh S; Hirst S; Valdez C; Randall A; Molina D; Liang X; Freilich DA; Oloo JA; Blair PL; Aguiar JC; Baldi P; Davies DH; Felgner PL
Proteomics; 2008 Nov; 8(22):4680-94. PubMed ID: 18937256
[TBL] [Abstract][Full Text] [Related]
10. RTS,S/AS01E immunization increases antibody responses to vaccine-unrelated Plasmodium falciparum antigens associated with protection against clinical malaria in African children: a case-control study.
Dobaño C; Ubillos I; Jairoce C; Gyan B; Vidal M; Jiménez A; Santano R; Dosoo D; Nhabomba AJ; Ayestaran A; Aguilar R; Williams NA; Díez-Padrisa N; Lanar D; Chauhan V; Chitnis C; Dutta S; Gaur D; Angov E; Asante KP; Owusu-Agyei S; Valim C; Gamain B; Coppel RL; Cavanagh D; Beeson JG; Campo JJ; Moncunill G
BMC Med; 2019 Aug; 17(1):157. PubMed ID: 31409398
[TBL] [Abstract][Full Text] [Related]
11. The Plasmodium falciparum Cell-Traversal Protein for Ookinetes and Sporozoites as a Candidate for Preerythrocytic and Transmission-Blocking Vaccines.
Espinosa DA; Vega-Rodriguez J; Flores-Garcia Y; Noe AR; Muñoz C; Coleman R; Bruck T; Haney K; Stevens A; Retallack D; Allen J; Vedvick TS; Fox CB; Reed SG; Howard RF; Salman AM; Janse CJ; Khan SM; Zavala F; Gutierrez GM
Infect Immun; 2017 Feb; 85(2):. PubMed ID: 27895131
[TBL] [Abstract][Full Text] [Related]
12. Antibody profiles to wheat germ cell-free system synthesized Plasmodium falciparum proteins correlate with protection from symptomatic malaria in Uganda.
Kanoi BN; Takashima E; Morita M; White MT; Palacpac NM; Ntege EH; Balikagala B; Yeka A; Egwang TG; Horii T; Tsuboi T
Vaccine; 2017 Feb; 35(6):873-881. PubMed ID: 28089547
[TBL] [Abstract][Full Text] [Related]
13. Sterile protection against human malaria by chemoattenuated PfSPZ vaccine.
Mordmüller B; Surat G; Lagler H; Chakravarty S; Ishizuka AS; Lalremruata A; Gmeiner M; Campo JJ; Esen M; Ruben AJ; Held J; Calle CL; Mengue JB; Gebru T; Ibáñez J; Sulyok M; James ER; Billingsley PF; Natasha KC; Manoj A; Murshedkar T; Gunasekera A; Eappen AG; Li T; Stafford RE; Li M; Felgner PL; Seder RA; Richie TL; Sim BK; Hoffman SL; Kremsner PG
Nature; 2017 Feb; 542(7642):445-449. PubMed ID: 28199305
[TBL] [Abstract][Full Text] [Related]
14. Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-gamma/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection.
Cummings JF; Spring MD; Schwenk RJ; Ockenhouse CF; Kester KE; Polhemus ME; Walsh DS; Yoon IK; Prosperi C; Juompan LY; Lanar DE; Krzych U; Hall BT; Ware LA; Stewart VA; Williams J; Dowler M; Nielsen RK; Hillier CJ; Giersing BK; Dubovsky F; Malkin E; Tucker K; Dubois MC; Cohen JD; Ballou WR; Heppner DG
Vaccine; 2010 Jul; 28(31):5135-44. PubMed ID: 19737527
[TBL] [Abstract][Full Text] [Related]
15. Identification of Plasmodium falciparum reticulocyte binding protein homologue 5-interacting protein, PfRipr, as a highly conserved blood-stage malaria vaccine candidate.
Ntege EH; Arisue N; Ito D; Hasegawa T; Palacpac NMQ; Egwang TG; Horii T; Takashima E; Tsuboi T
Vaccine; 2016 Nov; 34(46):5612-5622. PubMed ID: 27692771
[TBL] [Abstract][Full Text] [Related]
16. RTS,S vaccination is associated with serologic evidence of decreased exposure to Plasmodium falciparum liver- and blood-stage parasites.
Campo JJ; Aponte JJ; Skinner J; Nakajima R; Molina DM; Liang L; Sacarlal J; Alonso PL; Crompton PD; Felgner PL; Dobaño C
Mol Cell Proteomics; 2015 Mar; 14(3):519-31. PubMed ID: 25547414
[TBL] [Abstract][Full Text] [Related]
17. Immunity to recombinant plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity.
Singh S; Miura K; Zhou H; Muratova O; Keegan B; Miles A; Martin LB; Saul AJ; Miller LH; Long CA
Infect Immun; 2006 Aug; 74(8):4573-80. PubMed ID: 16861644
[TBL] [Abstract][Full Text] [Related]
18. Detection of CD4+CD45RO+ T lymphocytes producing IL-4 in response to antigens on Plasmodium falciparum erythrocytes: an in vitro correlate of protective immunity induced with attenuated Plasmodium falciparum sporozoites.
Bergmann ES; Ballou RW; Krzych U
Cell Immunol; 1997 Sep; 180(2):143-52. PubMed ID: 9341744
[TBL] [Abstract][Full Text] [Related]
19. The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody.
Douglas AD; Williams AR; Illingworth JJ; Kamuyu G; Biswas S; Goodman AL; Wyllie DH; Crosnier C; Miura K; Wright GJ; Long CA; Osier FH; Marsh K; Turner AV; Hill AV; Draper SJ
Nat Commun; 2011 Dec; 2():601. PubMed ID: 22186897
[TBL] [Abstract][Full Text] [Related]
20. Sporozoite immunization of human volunteers under chemoprophylaxis induces functional antibodies against pre-erythrocytic stages of Plasmodium falciparum.
Behet MC; Foquet L; van Gemert GJ; Bijker EM; Meuleman P; Leroux-Roels G; Hermsen CC; Scholzen A; Sauerwein RW
Malar J; 2014 Apr; 13():136. PubMed ID: 24708526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
